Literature DB >> 276528

Hemin control of heme biosynthesis in mouse Friend virus-transformed erythroleukemia cells in culture.

J L Granick, S Sassa.   

Abstract

Hemin treatment of mouse Friend virus-transformed cells in cultured caused a dose-dependent increase in hemoglobin synthesis. By the addition of radioactively labeled hemin and by the analysis of the radioactive heme in hemoglobin, only 60 to 70% of heme in the newly synthesized hemoglobin was accounted for by the exogenously added hemin. In keeping with this finding, hemin treatment increased the activity of two enzymes in the heme biosynthetic activity, i.e. delta-aminolevulinate (ALA) dehydratase and uroporphyrinogen-I (URO) synthase in these cells. Incorporation of [2(-14C)]glycine, [14C]ALA, and 59Fe into heme was also significantly increased in the cells treated with hemin, suggesting that essentially all enzyme activities in the heme biosynethetic pathway were increased after hemin treatment. These results indicate that heme in the newly synthesized hemoglobin in hemin-treated Friend cells derives both from hemin added to the culture and from heme synthesized intracellularly. In addition, these results suggest that the stimulation of heme biosynthesis by hemin in Friend virus-transformed cells is in contrast to the hemin repression of heme biosynthesis in liver cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 276528

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  delta-Aminolaevulinate synthase in human HepG2 hepatoma cells. Repression by haemin and induction by chemicals.

Authors:  F Iwasa; S Sassa; A Kappas
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.

Authors:  R D Levere; Y F Gong; A Kappas; D J Bucher; G P Wormser; N G Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  In heme catabolism C2 and C4 vinyl groups reduction of cobalt protoporphyrin forms cobalt mesoporphyrin and alters the nature of action of the metalloporphyrin in vivo.

Authors:  R Chandra; R Malhotra; M Dhawan; N Kumaria
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

4.  Uroporphyrinogen I synthase induction in normal human bone marrow cultures: an early and quantitative response of erythroid differentiation.

Authors:  S Sassa; A Urabe
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Inhibition of ferrochelatase during differentiation of murine erythroleukaemia cells.

Authors:  A Fadigan; H A Dailey
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

6.  Isolation and identification of a cDNA clone coding for rat uroporphyrinogen decarboxylase.

Authors:  P H Romeo; A Dubart; B Grandchamp; H de Verneuil; J Rosa; Y Nordmann; M Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Abnormal haem biosynthesis in the chronic anaemia of rheumatoid arthritis.

Authors:  T Houston; M Moore; D Porter; R Sturrock; E Fitzsimons
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

8.  Porphyrin-heme biosynthesis in organotypic cultures of mouse dorsal root ganglia. Effects of heme and lead on porphyrin synthesis and peripheral myelin.

Authors:  W O Whetsell; S Sassa; A Kappas
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons.

Authors:  T Ingi; G Chiang; G V Ronnett
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

10.  Crystal structure of Bfr A from Mycobacterium tuberculosis: incorporation of selenomethionine results in cleavage and demetallation of haem.

Authors:  Vibha Gupta; Rakesh K Gupta; Garima Khare; Dinakar M Salunke; Anil K Tyagi
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.